http://www.onemedplace.com/blog/wp-content/uploads/2010/01/biomoda1.jpg
Biomoda's CyPath diagnostic assay is based on molecular marker technology originally developed at the Los Alamos National Laboratory.
View ArticleBiomoda, Inc. at the 2010 OneMedForum
John Cousins, President and CEO of Biomoda, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/07/nyc-sea-in-the-ski...
The mid-year conference's goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional...
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/06/new-york-city.jpg
The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries.
View Article
More Pages to Explore .....
